Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio

investor.sagerx.com/news-releases/news-release-details/supernus-pharmaceuticals-acquire-sage-therapeutics-strengthening

Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
Proposed acquisition expected to accelerate mid- to long-term revenue and cash flow growth and further diversify revenue base.
Strengthens Supernus’ leading presence in…

This story appeared on investor.sagerx.com, 2025-06-16 15:04:35.490000.
The Entire Business World on a Single Page. Free to Use →